Kathryn A. Romano
Net Worth

Last updated:

What is Kathryn A. Romano net worth?

The estimated net worth of Ms. Kathryn A. Romano is at least $10,034,785 as of 28 Feb 2024. She owns shares worth $1,862,267 as insider, has earned $7,770,778 from insider trading and has received compensation worth at least $401,740 in Krystal Biotech, Inc..

What is the salary of Kathryn A. Romano?

Ms. Kathryn A. Romano salary is $200,870 per year as Chief Accounting Officer in Krystal Biotech, Inc..

How old is Kathryn A. Romano?

Ms. Kathryn A. Romano is 44 years old, born in 1981.

What stocks does Kathryn A. Romano currently own?

As insider, Ms. Kathryn A. Romano owns shares in one company:

Company Title Shares Price per share Total value
Krystal Biotech, Inc. (KRYS) Chief Accounting Officer 12,936 $143.96 $1,862,267

What does Krystal Biotech, Inc. do?

Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome. Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx product. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.

KRYS logo
KRYS
Krystal Biotech, Inc.
$143.96

Kathryn A. Romano insider trading

Krystal Biotech, Inc.

Ms. Kathryn A. Romano has made 5 insider trades between 2023-2024, according to the Form 4 filled with the SEC.

The largest trade she's ever made was exercising 25,000 units of KRYS stock on 19 May 2023. As of 28 Feb 2024 she still owns at least 12,936 units of KRYS stock.

Transaction Date Security Shares Price per share Total value Source
Option
Common Stock 203 $63.55 $12,901
Option
Common Stock 200 $63.55 $12,710
Option
Performance Stock Units 5,000 N/A N/A
Option
Common Stock 210 $63.55 $13,346
Option
Common Stock 300 $63.55 $19,065
Option
Common Stock 523 $63.55 $33,237
Option
Common Stock 637 $63.55 $40,481
Option
Common Stock 648 $63.55 $41,180
Option
Common Stock 700 $63.55 $44,485
Option
Common Stock 744 $63.55 $47,281
Option
Common Stock 786 $63.55 $49,950
Option
Common Stock 900 $63.55 $57,195
Option
Common Stock 1,133 $63.55 $72,002
Option
Common Stock 1,216 $63.55 $77,277
Option
Common Stock 1,429 $63.55 $90,813
Option
Common Stock 1,600 $63.55 $101,680
Option
Common Stock 5,000 N/A N/A
Option
Stock Option (Right to Buy) 5,000 $63.55 $317,750
Option
Stock Option (Right to Buy) 5,000 $63.55 $317,750
Option
Stock Option (Right to Buy) 2,500 $63.55 $158,875
Sale
Common Stock 12,200 $166.95 $2,036,766
Option
Common Stock 90 $63.55 $5,720
Option
Common Stock 100 $63.55 $6,355
Option
Common Stock 117 $63.55 $7,435
Option
Common Stock 130 $63.55 $8,262
Option
Common Stock 134 $63.55 $8,516
Option
Common Stock 1,913 $52.26 $99,973
Option
Common Stock 5,000 $52.26 $261,300
Option
Common Stock 3,087 $52.26 $161,327
Option
Common Stock 2,500 $52.26 $130,650
Sale
Common Stock 2,500 $130 $325,000
Option
Stock Option (Right to Buy) 2,500 $52.26 $130,650
Option
Common Stock 3,154 $52.26 $164,828
Option
Common Stock 1,300 $52.26 $67,938
Option
Stock Option (Right to Buy) 12,500 $52.26 $653,250
Option
Stock Option (Right to Buy) 12,500 $63.55 $794,375
Option
Common Stock 2,521 $52.26 $131,747
Option
Common Stock 2,570 $52.26 $134,308
Option
Common Stock 2,955 $52.26 $154,428
Sale
Common Stock 25,000 $108.28 $2,706,900
Option
Common Stock 12,500 $63.55 $794,375
Option
Stock Option (Right to Buy) 12,500 $52.26 $653,250
Option
Common Stock 12,500 $52.26 $653,250
Sale
Common Stock 25,000 $95.05 $2,376,175
Option
Stock Option (Right to Buy) 12,500 $52.26 $653,250
Sale
Common Stock 3,428 $95.08 $325,938

Krystal Biotech key executives

Krystal Biotech, Inc. executives and other stock owners filed with the SEC: